These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5125060)

  • 1. [On some effects of amantadine in muscle potentials in parkinsonism].
    Laterza A; Jandolo B; Sinibaldi L
    Minerva Med; 1971 Oct; 62(82):3987-9. PubMed ID: 5125060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
    Fünfgeld EW
    Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of amantadine in the treatment of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):3952-4. PubMed ID: 5125049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of amantadine in parkinsonism].
    Crudeli R; Candia O
    Minerva Med; 1971 Oct; 62(82):3963-4. PubMed ID: 5125053
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Parkinsonism with amantadine hydrochloride.
    Pa Med; 1971 Apr; 74(4):54-5. PubMed ID: 5147644
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amantadine therapy in parkinsonism].
    Blomberg LH
    Lakartidningen; 1972 Nov; 69(46):5339. PubMed ID: 4650741
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of amantadine on tardive dyskinesia and pseudo-parkinsonism.
    Janowsky DS; el-Yousef MK; Davis JM; Sekerke HJ; Morris DR; Decker B
    N Engl J Med; 1972 Apr; 286(14):785. PubMed ID: 4554521
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term therapy of parkinsonism using amantadine salts].
    Damielczyk W; Struppler A; Velho-Groneberg P; Clemens R; Diehl LW
    Med Welt; 1976 Apr; 27(14):669-75. PubMed ID: 1263820
    [No Abstract]   [Full Text] [Related]  

  • 10. L-dopa and amantadine for Parkinsonism.
    Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic association of amantadine and L-Dopa in parkinsonism].
    Signorelli CD; D'Andrea F; De Divitiis E; Cerillo A
    Minerva Med; 1971 Oct; 62(82):4015-6. PubMed ID: 5125068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electromyographic aspects of laro-dopa therapy].
    Càmpeanu E; Mareş V; Dumitru E; Kory S
    Neurol Psihiatr Neurochir; 1973; 18(6):551-8. PubMed ID: 4790487
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amantadine treatment in parkinsonism].
    Holmsen R
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current treatment of Parkinsonism with amantadine hydrochloride].
    Gerstenbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 Jul; 27(23):878-9. PubMed ID: 5040531
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects].
    Puca FM; Pigneri MT
    Boll Soc Ital Biol Sper; 1972 May; 48(9):237-40. PubMed ID: 5070096
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
    De Divitiis E; D'Andrea F; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):4007-8. PubMed ID: 5125065
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
    [No Abstract]   [Full Text] [Related]  

  • 20. The antiparkinson properties of amantadine in drug-induced parkinsonism.
    Kelly JT; Abuzzahab FS
    J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.